CONTEXT AND OBJECTIVE: In children, hepatic steatosis may be related to inborn errors of metabolism (IEMs) or to non-alcoholic fatty liver disease (NAFLD). The aim of this study was to assess and characterize steatosis of indeterminate cause through morphological and morphometric analysis of liver tissue. METHODS: Eighteen consecutive liver biopsies obtained from 16 patients of ages ranging from 3 months to 12 years and nine months that were inserted in a database in the study period were analyzed using optical microscopy and transmission electron microscopy. Through electron microscopy, the mitochondrial density and mean mitochondrial surface area were determined in hepatocytes. Ten patients ranging in age from 1 to 14 years were used as a control group. RESULTS: "Pure" steatosis was detected, unaccompanied by fibrosis or any other histological alteration. Microvesicular steatosis predominated, with a significant increase in mean mitochondrial surface area. CONCLUSION: Microvesicular steatosis may be related to primary mitochondrial hepatopathy, especially due to reduction of b-oxidation or partial stagnation of oxidative phosphorylation. For these reasons, this form of steatosis (which should not be called "pure") is likely to represent an initial stage in the broad spectrum of NAFLD. We have drawn attention to cases of steatosis in the pediatric group, in which the microvesicular form predominates, since this may be associated with mitochondrial disorders.
INTRODUCTION
In children, the presence of steatosis is generally related to inborn errors of metabolism (IEMs). The clinical presentation varies and includes changes to general health condition; neurological, digestive and respiratory disorders; rapid and progressive neurological deterioration; myopathy; cardiomyopathy; craniofacial dysmorphism etc. Some forms of the disease present essentially as liver disease with hepatomegaly, jaundice, vomiting, lethargy and abnormalities of liver function.
When these diseases are ruled out after clinical and laboratory investigation, non-alcoholic fatty liver disease (NAFLD) should be considered. This term, which was initially used for adults, has become more inclusive. 1 It is currently used to describe all age groups, even children. 2, 3 In more recent years, several studies on childhood 4 and adolescent hepatic steatosis in cases of NAFLD have been conducted, especially in relation to obese children, [5] [6] [7] [8] [9] [10] [11] [12] [13] since the prevalence of NAFLD is higher in these types of children. In a pediatric group, the risk factors for NAFLD include obesity, insulin resistance and hypertriglyceridemia. 14 The major features are a higher rate in male children, with serum alanine aminotransferase (ALT) levels that are usually higher than serum aspartate aminotransferase (AST) levels, and with hypertriglyceridemia and vague abdominal pain (which is usually the main reason for seeking clinical evaluation). [14] [15] [16] According to Mandel et al. 17 and Bioulac-Sage et al., 18 childhood microvesicular steatosis may be associated with mitochondrial abnormalities relating to increased numbers of organelles. 18, 19 There is also a correlation with respiratory chain defects and consequently impaired oxidative phosphorylation. 20, 21 When this type of abnormality occurs, transfer of electrons to oxygen molecules generates reactive oxygen species, thus producing superoxide anions and hydrogen peroxide. 22 Furthermore, with stagnation of mitochondrial oxidative capacity, fatty acids accumulate in the cytosol, thus reaffirming the close relationship between steatosis and mitochondriopathy. The microvesicular form alone may also be associated with some clinical conditions, such as Reye's syndrome, Jamaican vomiting sickness and congenital deficiency of b-oxidation. 23 In an experimental study on pigs, it was observed that the regenerative capacity of the hepatocytes in macrovesicular steatosis was more effective than in microvesicular steatosis, thereby implying that the latter has a less favorable prognosis. 24 The cases that were studied did not have any clinical association with any previously cited factor and the findings were correlated with clinical and laboratory data. There is a continuing debate on the advisability of performing liver biopsy, because of the risk of complications, high costs and lack of effective therapy.
However, liver biopsy is the only precise diagnostic method, and it is essential for grading and staging the disease. Furthermore, it enables patient inclusion in clinical screening programs.
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OBJECTIVE
The aim of our study was to evaluate and characterize "pure" steatosis in a pediatric group by means of morphological (optical and electron microscopy) and morphometric analysis. The liver specimens were obtained by means of percutaneous biopsy and were processed using optical microscopy and transmission electron microscopy (TEM). For optical microscopy, the specimens were fixed in 10% formalin and processed for embed- steatosis between the patients and controls was evaluated using analysis of variance (ANOVA) with log transformation. P values < 0.05 were arbitrarily taken to be significant ("acceptable error limit"). The total steatosis ranged from one to four and the microvesicular steatosis ranged from five to 95%. Considerable variation was found in the degree of steatosis, as well as in the percentage of microvesicular steatosis compared with macrovesicular steatosis. Because of this variation, the patients were allocated into two groups: the first group was composed of patients with predominantly (> 50%) microvesicular steatosis (n = 11); and the second group was composed of patients with predominantly (≤ 50%) macrovesicular steatosis (n = 7).
MATERIAL AND METHODS
All
RESULTS
All
Marked variation in hepatic enzyme values was observed.
The AST levels ranged from 20 to 304 U/I; ALT from 17 to 386 U/I; and gamma-glutamyl transpeptidase (GGT) from 15 to 585 U/I. In Table 1 , the biochemical parameters, weight and height of each patient are shown.
Analysis on the mitochondrial ultrastructure showed that the most frequent morphological abnormalities were megamitochondria, with or without crystalline inclusions, and a highly irregular mitochondrial shape, with degenerative changes (decreased electron density and loss of cristae).
Morphometric analysis on mitochondrial density showed that there were no significant differences between the control group, microvesicular steatosis group and macrovesicular Analysis on the mean mitochondrial surface area showed that there was a significant difference between the microvesicular steatosis group and the control and macrovesicular steatosis groups. These results are presented in Figure 3 and images are shown in Figure 4 .
DISCUSSION
Since mitochondria are the sites for many metabolic processes (such as tricarboxylic acid production, fatty acid β-oxidation, synthesis of urea and other substances, and use of glucose and fatty acids as fuels for ATP synthesis), a disorder in any of these mechanisms may cause severe damage to the cell and thus to the tissue. Respiratory chain defects are not rare and are known to cause early liver failure in infancy, 21 thereby leading to a change in fatty acid oxidation. 27 Changes to mitochondrial β-oxidation may result in accumulation of fatty acids in the cytosol, and this is typically represented by microvesicular steatosis. 28, 29 In our study, a significant elevation in mean mitochondrial surface area was observed, and this proved to be substantial in the patients with predominantly microvesicular steatosis. In contrast, the mitochondria in the patients with predominantly macrovesicular steatosis were considered to be normal in size. These In our case study, 64% of the patients with microvesicular steatosis and 57% of the patients with macrovesicular steatosis showed an elevation in at least one hepatic serum aminotrans- The mechanisms that induce mitochondrial "hypertrophy" remain obscure. However, changes to the respiratory chain or to other mitochondrial metabolic enzymes, whether inborn or acquired, may lead to an increase in b-oxidation and partial stagnation of oxidative phosphorylation (OxP). We hypothesize that an increase in mitochondrial volume occurs as a consequence.
As a result, the volumes of the inner membrane (and cristae) and inner membrane space (sites relating to b-oxidation and OxP) increase in an attempt to compensate for metabolic processes that were partially or totally interrupted. Taking into account the "twohit" hypothesis proposed by Day and James 35 to explain the pathogenesis of NAFLD, it is important to note that steatosis by itself does not cause the development of liver disease. However, it is a factor that can sensitize the liver to the damaging effects of a "second hit. " Therefore, factors causing innocuous stress in healthy livers may lead to the development of NASH in steatotic livers. 36 The results from this study have contributed substantially towards evaluations on childhood steatosis of indeterminate cause, drawing close attention to cases with predominantly microvesicular steatosis. No similar studies on pediatric groups have been published in the literature, and we would particularly like to highlight that the data on the control group in this study, which has also never previously been published, may be useful as a reference for conducting other electron microscopy studies on pediatric livers.
CONCLUSION
It may be concluded from our results that changes to serum transaminases and the presence of macrovesicular steatosis in this pediatric group did not correlate with changes to mitochondrial density or size. In addition, increased mitochondrial size was probably a morphological expression relating to deranged beta-oxidation and partial stagnation of oxidative phosphorylation. This therefore supports the hypothesis that there may be a mild form of primary mitochondrial hepatopathy, which may then progress in a more worrisome manner, especially as a second hit.
